You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ALLOPURINOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Allopurinol patents expire, and what generic alternatives are available?

Allopurinol is a drug marketed by Accord Hlthcare, Aiping Pharm Inc, Chartwell, Harman Finochem, Hetero Labs Ltd V, Indoco, Ipca Labs Ltd, Lupin Ltd, Mutual Pharm, Mylan, Northstar Hlthcare, Puracap Pharm, Purepac Pharm, Sandoz, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, Unichem, Vintage Pharms, Watson Labs, Zydus Pharms, Gland Pharma Ltd, and Hikma. and is included in thirty NDAs.

The generic ingredient in ALLOPURINOL is allopurinol sodium. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Allopurinol

A generic version of ALLOPURINOL was approved as allopurinol sodium by HIKMA on August 26th, 2004.

  Try a Trial

Drug patent expirations by year for ALLOPURINOL
Drug Prices for ALLOPURINOL

See drug prices for ALLOPURINOL

Drug Sales Revenue Trends for ALLOPURINOL

See drug sales revenues for ALLOPURINOL

Recent Clinical Trials for ALLOPURINOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Dana-Farber Cancer InstitutePhase 2
Eli Lilly and CompanyPhase 2
VA Office of Research and DevelopmentPhase 2

See all ALLOPURINOL clinical trials

Pharmacology for ALLOPURINOL
Medical Subject Heading (MeSH) Categories for ALLOPURINOL

US Patents and Regulatory Information for ALLOPURINOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs ALLOPURINOL allopurinol TABLET;ORAL 018785-002 Sep 28, 1984 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Superpharm ALLOPURINOL allopurinol TABLET;ORAL 070951-001 Nov 30, 1988 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Gland Pharma Ltd ALLOPURINOL SODIUM allopurinol sodium INJECTABLE;INJECTION 212363-001 Jan 26, 2022 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sun Pharm Inds Inc ALLOPURINOL allopurinol TABLET;ORAL 078390-002 Aug 30, 2007 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Unichem ALLOPURINOL allopurinol TABLET;ORAL 211820-001 Mar 12, 2019 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.